Remove 03 24 pharma-law-policy-research-february-2023
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

ANVISA Resumes Inspections in the Area of Technovigilance, 29 March 2023 In partnership with local Health Surveillance, ANVISA technical teams carried out in March 2023 two (2) medical device manufacturer inspections with an aim to strengthen the monitoring of these products in Brazil, ensuring their safety, performance, and quality.

FDA 40